Expertise in
17
conditions

Dr. Jeffrey A. Forquer

Radiation Oncology
ProMedica Hickman Cancer Center On The Campus Of ProMedica Flower Hospital
5300 Harroun Rd Ste 010, 
Sylvania, OH 
Accepting New Patients
Offers Telehealth
Expertise in
17
conditions
ProMedica Hickman Cancer Center On The Campus Of ProMedica Flower Hospital
5300 Harroun Rd Ste 010, 
Sylvania, OH 

Overview

Jeffrey Forquer is a Radiation Oncologist practicing medicine in Sylvania, Ohio.

Dr. Forquer is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Endometrial Cancer.

He is actively involved in clinical research, participating in 5 clinical trials. Dr. Forquer is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in MI

Hospital Affiliations

University Of Michigan Health System
Promedica Toledo Hospital
Promedica Defiance Regional Hospital
Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

ProMedica Hickman Cancer Center on the Campus of ProMedica Flower Hospital
5300 Harroun Rd Ste 010, Sylvania, OH 43560

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: August 27, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
23
conditions
Dr. Daniel R. Wahl
Radiation Oncology
Expertise in
23
conditions
Dr. Daniel R. Wahl
Radiation Oncology
Referral may be required

University Hospital

1500 E Medical Center Dr, Floor B2 C490, 
Ann Arbor, MI 
 (40.2 miles away)
734-936-4300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wahl is currently accepting new patients.

Expertise in
11
conditions
Dr. Avraham Eisbruch
Radiation Oncology
Expertise in
11
conditions
Dr. Avraham Eisbruch
Radiation Oncology
Referral may be required

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor, MI 
 (40.2 miles away)
734-936-4300
Languages Spoken:
English

Avraham Eisbruch is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Eisbruch is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Dry Mouth, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Expertise in
14
conditions
Dr. Mohamed A. Elshaikh
Radiation Oncology
Expertise in
14
conditions
Dr. Mohamed A. Elshaikh
Radiation Oncology
Referral may be required

Henry Ford Cancer-Detroit

2800 W Grand Blvd, 
Detroit, MI 
 (57.0 miles away)
888-777-4167
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mohamed Elshaikh is a Radiation Oncologist practicing medicine in Detroit, Michigan. Dr. Elshaikh is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Prostate Cancer, Cervical Cancer, Familial Prostate Cancer, and Lymphadenectomy. Dr. Elshaikh is currently accepting new patients.

Frequently Asked Questions about Dr. Jeffrey A. Forquer

How do I make an appointment with Dr. Jeffrey A. Forquer?

You can book an appointment with Dr. Jeffrey A. Forquer by calling their office at 419-824-1952. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey A. Forquer a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey A. Forquer is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey A. Forquer specialize in?

While Dr. Jeffrey A. Forquer is a Radiation Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Jeffrey A. Forquer accept my insurance?

Dr. Jeffrey A. Forquer accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 419-824-1952 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Forquer's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 64 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile